DK1140147T3 - hCG-terapi til behandling af metastatisk brystcancer - Google Patents

hCG-terapi til behandling af metastatisk brystcancer

Info

Publication number
DK1140147T3
DK1140147T3 DK99967331T DK99967331T DK1140147T3 DK 1140147 T3 DK1140147 T3 DK 1140147T3 DK 99967331 T DK99967331 T DK 99967331T DK 99967331 T DK99967331 T DK 99967331T DK 1140147 T3 DK1140147 T3 DK 1140147T3
Authority
DK
Denmark
Prior art keywords
treatment
breast cancer
metastatic breast
hcg therapy
hcg
Prior art date
Application number
DK99967331T
Other languages
Danish (da)
English (en)
Inventor
Giampiero Deluca
Jaak Ph Janssens
Irma H Russo
Jose Russo
Original Assignee
Fox Chase Cancer Ct
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Ct, Applied Research Systems filed Critical Fox Chase Cancer Ct
Application granted granted Critical
Publication of DK1140147T3 publication Critical patent/DK1140147T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99967331T 1998-12-15 1999-12-15 hCG-terapi til behandling af metastatisk brystcancer DK1140147T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98123817A EP1013281A1 (fr) 1998-12-15 1998-12-15 hCG therapie pour le traitement du cancer du sein
PCT/US1999/029795 WO2000035469A2 (fr) 1998-12-15 1999-12-15 Therapie a base de gonadotrophine chorionique destinee au traitement du cancer du sein

Publications (1)

Publication Number Publication Date
DK1140147T3 true DK1140147T3 (da) 2007-03-26

Family

ID=8233138

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99967331T DK1140147T3 (da) 1998-12-15 1999-12-15 hCG-terapi til behandling af metastatisk brystcancer

Country Status (16)

Country Link
US (1) US7183251B1 (fr)
EP (2) EP1013281A1 (fr)
JP (1) JP2003523311A (fr)
AR (1) AR023726A1 (fr)
AT (1) ATE353664T1 (fr)
AU (1) AU781495B2 (fr)
BR (1) BR9916221A (fr)
CA (1) CA2351726A1 (fr)
CY (1) CY1106525T1 (fr)
DE (1) DE69935156T2 (fr)
DK (1) DK1140147T3 (fr)
ES (1) ES2277461T3 (fr)
IL (2) IL143671A0 (fr)
PT (1) PT1140147E (fr)
SI (1) SI1140147T1 (fr)
WO (1) WO2000035469A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515818A (ja) * 2004-10-07 2008-05-15 ステム セル セラピューティクス コーポレイション 妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激
US8968210B2 (en) * 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160699B1 (fr) 1983-11-02 1992-08-12 Applied Research Systems Ars Holding N.V. Production d'hormones heterodimeriques de la fertilite chez l'homme
US5677275A (en) 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
US5700781A (en) 1994-10-04 1997-12-23 Harris; Pamela Jo Method for treating Kaposi's sarcoma and HIV infections
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
WO2000035469A2 (fr) 2000-06-22
PT1140147E (pt) 2007-03-30
AR023726A1 (es) 2002-09-04
CY1106525T1 (el) 2012-01-25
WO2000035469A3 (fr) 2000-09-14
AU781495B2 (en) 2005-05-26
JP2003523311A (ja) 2003-08-05
DE69935156T2 (de) 2007-11-22
IL143671A (en) 2009-08-03
EP1140147A2 (fr) 2001-10-10
WO2000035469A9 (fr) 2001-03-22
BR9916221A (pt) 2001-09-11
EP1013281A1 (fr) 2000-06-28
EP1140147B1 (fr) 2007-02-14
CA2351726A1 (fr) 2000-06-22
IL143671A0 (en) 2002-04-21
ATE353664T1 (de) 2007-03-15
ES2277461T3 (es) 2007-07-01
AU2363100A (en) 2000-07-03
SI1140147T1 (sl) 2007-06-30
US7183251B1 (en) 2007-02-27
DE69935156D1 (de) 2007-03-29

Similar Documents

Publication Publication Date Title
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
EE200200673A (et) Kinasoliini derivaadid kasvajate raviks
ITMI990375A1 (it) Trattamento del cancro co epotiloni
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
IS6375A (is) Lyfjagjöf til öftrunar á blöðruhálskrabbameini
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
DK0942754T3 (da) Konjugater anvendelige til behandlingen af prostatacancer
DK1176964T3 (da) Brug af ET743 til behandling af cancer
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
NO974972L (no) FremgangsmÕte for Õ hindre brystcancer
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
GB2389532C (en) The method of treating cancer
DE60024243D1 (de) Verbesserte krebsbehandlung mit temozolomid
DK1140147T3 (da) hCG-terapi til behandling af metastatisk brystcancer
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
HUP0101947A3 (en) Combination for the treatment of tumors
DK1054868T3 (da) Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi
NO20014228D0 (no) Radioaktiv cisplatin i behandling av cancer
ZA200203166B (en) Treatment of cancer.
GB9804361D0 (en) Cancer treatment
UA34019A (uk) Спосіб консервативного лікування злоякісних пухлин стравоходу
ES1039862Y (es) Plantilla terapeutica
NO996166L (no) FremgangsmÕte for behandling av avluter
UA34018A (uk) Спосіб консервативного лікування злоякісних пухлин
GB9820000D0 (en) Cancer treatment